Global
Because IT is a driving force for hospital development, CEOs must make it a priority, says Huimin Xia, CEO of the Stage 7 EMRAM validated Guangzhou Women and Children's Medical Center.
Silver Lake led the round, which will be used for new partnerships, global business development, and potential acquisitions.
Otsuka intends to invest more than $300 million in an FDA-cleared software app that will apply cognitive therapy principals either with or without prescription drugs.
The SurroSense Rx system will be available to Onduo's members in 2019.
The prescription digital therapeutic will give users interactive therapy lessons to be use by patients under a clinician's supervision.
ResMed is expected to close the $225M deal to purchase the smart inhaler company by March 2019.
Keyto's platform measures biomarkers in a user's breath to gauge the state of their metabolism.
First announced in March, the program allows participants to pay off the device's cost by meeting daily fitness goals.